Current and Future Burden of Prostate Cancer in Songkhla, Thailand: Analysis of Incidence and Mortality Trends From 1990 to 2030

Purpose Prostate cancer is the second most common malignancy among men worldwide, and it poses a significant public health burden that has traditionally been limited mostly to developed countries. However, the burden of the disease is expected to increase, affecting developing countries, including Thailand. We undertook an analysis to investigate current and future trends of prostate cancer in the province of Songkhla, Thailand, using data from the Songkhla Cancer Registry from 1990 to 2013. Methods Joinpoint regression analysis was used to examine trends in age-adjusted incidence and mortality rates of prostate cancer and provide estimated annual percent change (EAPC) with 95% CIs. Age-period-cohort (APC) models were used to assess the effect of age, calendar year, and birth cohort on incidence and mortality rates. Three different methods (Joinpoint, Nordpred, and APC) were used to project trends from 2013 to 2030. Results Eight hundred fifty-five cases of prostate cancer were diagnosed from 1990 to 2013 in Songkhla, Thailand. The incidence rates of prostate cancer significantly increased since 1990 at an EAPC of 4.8% (95% CI, 3.6% to 5.9%). Similarly, mortality rates increased at an EAPC of 5.3% (95% CI, 3.4% to 7.2%). The APC models suggest that birth cohort is the most important factor driving the increased incidence and mortality rates of prostate cancer. Future incidence and mortality of prostate cancer are projected to continue to increase, doubling the rates observed in 2013 by 2030. Conclusion It is critical to allocate resources to provide care for the men who will be affected by this increase in prostate cancer incidence in Songkhla, Thailand, and to design context-appropriate interventions to prevent its increasing burden.

Download Full-text

Incidence and Mortality of Prostate Cancer in Canada during 1992–2010

Current Oncology ◽

10.3390/curroncol28010096 ◽

2021 ◽

Vol 28 (1) ◽

pp. 978-990

Author(s):

François Lagacé ◽

Feras M. Ghazawi ◽

Michelle Le ◽

Evgeny Savin ◽

Andrei Zubarev ◽

...

Keyword(s):

Prostate Cancer ◽

Demographic Data ◽

Temporal Trends ◽

Cancer Registries ◽

Mortality Rates ◽

Incidence Rates ◽

Postal Code ◽

Mortality Trends ◽

Independent Population ◽

Incidence And Mortality

In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze demographic data on Canadian men diagnosed with prostate cancer and men who died of prostate cancer between the years of 1992 and 2010. The incidence and mortality rates were calculated at the provincial, city, and forward sortation area (FSA) postal code levels by using population counts that were obtained from the Canadian Census of Population. The Canadian average incidence rate was 113.57 cases per 100,000 males. There has been an overall increasing trend in crude prostate cancer incidence between 1992 and 2010 with three peaks, in 1993, 2001, and 2007. However, age-adjusted incidence rates showed no significant increase over time. The national mortality rate was calculated to be 24.13 deaths per 100,000 males per year. A decrease was noted in crude and age-adjusted mortality rates between 1992 and 2010. Several provinces, cities, and FSAs had higher incidence/mortality rates than the national average. Several of the FSA postal codes with the highest incidence/mortality rates were adjacent to one another. Several Canadian regions of high incidence for prostate cancer have been identified through this study and temporal trends are consistent with those reported in the literature. These results will serve as a foundation for future studies that will seek to identify new regional risk factors and etiologic agents.

Download Full-text

Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada

Current Oncology ◽

10.3747/co.26.4625 ◽

2019 ◽

Vol 26 (4) ◽

Cited By ~ 6

Author(s):

M. Le ◽

F. M. Ghazawi ◽

A. Alakel ◽

E. Netchiporouk ◽

E. Rahme ◽

...

Keyword(s):

Follicular Lymphoma ◽

Geographic Distribution ◽

Mortality Rates ◽

Vital Statistics ◽

Incidence Rates ◽

Western World ◽

Linear Regression Models ◽

Mortality Trends ◽

Comprehensive Overview ◽

Incidence And Mortality

Background Follicular lymphoma (FL) is the most common indolent lymphoma and the 2nd most common non- Hodgkin lymphoma, accounting for 10%–20% of all lymphomas in the Western world. Epidemiologic and geographic trends of FL in Canada have not been investigated. Our study’s objective was to analyze incidence and mortality rates and the geographic distribution of FL patients in Canada for 1992–2010.Methods Demographic and geographic patient data for FL cases were obtained using the Canadian Cancer Registry, the Registre quebecois du cancer, and the Canadian Vital Statistics database. Incidence and mortality rates and 95% confidence intervals were calculated per year and per geographic area. Rates were plotted using linear regression models to assess trends over time. Overall data were mapped using Microsoft Excel mapping software (Redmond, WA, U.S.A.) to identify case clusters across Canada.Results Approximately 22,625 patients were diagnosed with FL during 1992–2010. The age-standardized incidence rate of this malignancy in Canada was 38.3 cases per million individuals per year. Geographic analysis demonstrated that a number of Maritime provinces and Manitoba had the highest incidence rates, and that the provinces of Nova Scotia and Quebec had the highest mortality rates in the nation. Regional data demonstrated clustering of FL within cities or regions with high herbicide use, primary mining, and a strong manufacturing presence.Conclusions Our study provides a comprehensive overview of the FL burden and its geographic distribution in Canada. Regional clustering of this disease in concentrated industrial zones strongly suggests that multiple environmental factors might play a crucial role in the development of this lymphoma.

Download Full-text

Colorectal Cancer Incidence and Mortality Rates Among New York City Adults Ages 20–54 years during 1976–2015

JNCI Cancer Spectrum ◽

10.1093/jncics/pky048 ◽

2018 ◽

Vol 2 (4) ◽

Author(s):

Kellie C Van Beck ◽

John Jasek ◽

Kristi Roods ◽

Jennifer J Brown ◽

Shannon M Farley ◽

...

Keyword(s):

Colorectal Cancer ◽

New York ◽

New York City ◽

York City ◽

New York State ◽

Mortality Rates ◽

Registry Data ◽

Mortality Trends ◽

Annual Percent Change ◽

Incidence And Mortality

Abstract Colorectal cancer (CRC) incidence rates are rising in younger Americans and mortality rates are increasing among younger white Americans. We used New York State Cancer Registry data to examine New York City CRC incidence and mortality trends among adults ages 20–54 years by race from 1976 to 2015. Annual percent change (APC) was considered statistically significant at P less than .05 using a two-sided test. CRC incidence increased among those ages 20–49 years, yet blacks had the largest APC of 2.2% (1993–2015; 95% confidence interval [CI] = 1.4% to 3.1%) compared with 0.5% in whites (1976–2015; 95% CI = 0.2% to 0.7%). Among those aged 50–54 years, incidence increased among blacks by 0.8% annually (1976–2015; 95% CI = 0.4% to 1.1%), but not among whites. CRC mortality decreased among both age and race groups. These findings emphasize the value of local registry data to understand trends locally, the importance of timely screening, and the need for clinicians to consider CRC among all patients with compatible signs and symptoms.

Download Full-text

Contemporary incidence and mortality rates of kidney cancer in the United States

Canadian Urological Association Journal ◽

10.5489/cuaj.1760 ◽

2014 ◽

Vol 8 (7-8) ◽

pp. 247 ◽

Cited By ~ 55

Author(s):

Giorgio Gandaglia ◽

Praful Ravi ◽

Firas Abdollah ◽

Abd-El-Rahman M. Abd-El-Barr ◽

Andreas Becker ◽

...

Keyword(s):

Kidney Cancer ◽

The United States ◽

Mortality Rates ◽

Incidence Rates ◽

Short Term ◽

Annual Percent Change ◽

Cancer Specific Survival ◽

Incidence And Mortality ◽

Short Term Mortality ◽

Adjusted Incidence

Introduction: This is a timely update of incidence and mortality for renal cell carcinoma (RCC) in the United States.Methods: Relying on the Surveillance, Epidemiology, and End Results (SEER) database, we computed age-adjusted incidence, mortality rates and 5-year cancer-specific survival (CSS) for patients with histologically confirmed kidney cancer between 1975 and 2009. Long-term (1975–2009) and short-term (2000–2009) trends were examined by joinpoint analysis, and quantified using the annual percent change (APC). The reported findings were stratified according to disease stage.Results: Age-adjusted incidence rates of RCC increased by +2.76%/year between 1975 and 2009 (from 6.5 to 17.1/100 000 person years, p < 0.001), and by +2.85%/year between 2000 and 2009 (p < 0.001). For the same time points, the corresponding APC for the incidence of localized stage were +4.55%/year (from 3.0 to 12.2/100 000 person years, p < 0.001), and +4.42%/year (p < 0.001), respectively. The incidence rates of regional stage increased by +0.88%/year between 1975 and 2009 (p < 0.001), but stabilized in recent years (2000–2009: +0.56%/year, p = 0.4). Incidence rates of distant stage remained unchanged in long- and short-term trends. Overall mortality rates increased by +1.72%/year between 1975 and 2009 (from 1.2 to 5.0/100 000 person-years, P<0.001), but stabilized between 1994 and 2004 (p = 0.1). Short-term mortality rates increased in a significant fashion by +3.14%/year only for localized stage (p < 0.001).Interpretation: In contemporary years, there is a persisting upward trend in incidence and mortality of localized RCC.

Download Full-text

Social inequalities and the pandemic of COVID-19: the case of Rio de Janeiro

Journal of Epidemiology & Community Health ◽

10.1136/jech-2020-214724 ◽

2021 ◽

pp. jech-2020-214724

Author(s):

Julio Silva ◽

Marcelo Ribeiro-Alves

Keyword(s):

Socioeconomic Factors ◽

Rio De Janeiro ◽

Social Inequalities ◽

Developed Countries ◽

Mortality Rates ◽

Incidence Rates ◽

Vulnerable Groups ◽

Early Stages ◽

Incidence And Mortality ◽

Health Gradient

BackgroundThe novel coronavirus (SARS-CoV-2) is a global pandemic. The lack of protective vaccine or treatment led most of the countries to follow the flattening of the infection curve with social isolation measures. There is evidence that socioeconomic inequalities have been shaping the COVID-19 burden among low and middle-income countries. This study described what sociodemographic and socioeconomic factors were associated with the greatest risk of COVID-19 infection and mortality and how did the importance of key neighbourhood-level socioeconomic factors change over time during the early stages of the pandemic in the Rio de Janeiro municipality, Brazil.MethodsWe linked socioeconomic attributes to confirmed cases and deaths from COVID-19 and computed age-standardised incidence and mortality rates by domains such as age, gender, crowding, education, income and race/ethnicity.ResultsThe evidence suggests that although age-standardised incidence rates were higher in wealthy neighbourhoods, age-standardised mortality rates were higher in deprived areas during the first 2 months of the pandemic. The age-standardised mortality rates were also higher in males, and in areas with a predominance of people of colour, which are disproportionately represented in more vulnerable groups. The population also presented COVID-19 ‘rejuvenation’, that is, people became risk group younger than in developed countries.ConclusionWe conclude that there is a strong health gradient for COVID-19 death risk during the early stages of the pandemic. COVID-19 cases continued to move towards the urban periphery and to more vulnerable communities, threatening the health system functioning and increasing the health gradient.

Download Full-text

Incidence and mortality from colon and rectal cancer in Midwestern Brazil

Revista Brasileira de Epidemiologia ◽

10.1590/1980-5497201600040008 ◽

2016 ◽

Vol 19 (4) ◽

pp. 779-790

Author(s):

Anderson Gomes de Oliveira ◽

Maria Paula Curado ◽

Alice Koechlin ◽

José Carlos de Oliveira ◽

Diego Rodrigues Mendonça e Silva

Keyword(s):

Rectal Cancer ◽

Colon Cancer ◽

Cancer Mortality ◽

Mortality Rates ◽

Incidence Rates ◽

Similar Data ◽

Mortality Trends ◽

Colon And Rectal Cancer ◽

Incidence And Mortality ◽

Colon Cancer Mortality

ABSTRACT: Objective: To describe the incidence and mortality rates from colon and rectal cancer in Midwestern Brazil. Methods: Data for the incidence rates were obtained from the Population-Based Cancer Registry (PBCR) according to the available period. Mortality data were obtained from the Mortality Information System (SIM) for the period between 1996 and 2008. Incidence and mortality rates were calculated by gender and age groups. Mortality trends were analyzed by the Joinpoint software. The age-period-cohort effects were calculated by the R software. Results: The incidence rates for colon cancer vary from 4.49 to 23.19/100,000, while mortality rates vary from 2.85 to 14.54/100,000. For rectal cancer, the incidence rates range from 1.25 to 11.18/100,000 and mortality rates range between 0.30 and 7.90/100,000. Colon cancer mortality trends showed an increase among males in Cuiabá, Campo Grande, and Goiania. For those aged under 50 years, the increased rate was 13.2% in Campo Grande. For those aged over 50 years, there was a significant increase in the mortality in all capitals. In Goiânia, rectal cancer mortality in males increased 7.3%. For females below 50 years of age in the city of Brasilia, there was an increase of 8.7%, while females over 50 years of age in Cuiaba showed an increase of 10%. Conclusion: There is limited data available on the incidence of colon and rectal cancer for the Midwest region of Brazil. Colon cancer mortality has generally increased for both genders, but similar data were not verified for rectal cancer. The findings presented herein demonstrate the necessity for organized screening programs for colon and rectal cancer in Midwestern Brazil.

Download Full-text

Trends in Incidence and Mortality of Primary Liver Cancer in Lithuania 1998–2015

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph18031191 ◽

2021 ◽

Vol 18 (3) ◽

pp. 1191

Author(s):

Audrius Dulskas ◽

Povilas Kavaliauskas ◽

Kestutis Zagminas ◽

Ligita Jancoriene ◽

Giedre Smailyte

Keyword(s):

Liver Cancer ◽

Cancer Incidence ◽

Ductal Carcinoma ◽

Primary Liver Cancer ◽

Age Groups ◽

Developed Countries ◽

Mortality Rates ◽

Incidence Rates ◽

Incidence And Mortality ◽

Cancer Incidence Rates

Background: Recently, reports have suggested that rates of liver cancer have increased during the last decades in developed countries; increasing hepatocellular carcinoma and cholangiocarcinoma rates were reported. The aim of this study was to examine time trends in incidence and mortality rates of liver cancer for the period of 1998–2015 in Lithuania by sex, age, and histology. Methods: We examined the incidence of liver cancer from 1998 to 2015 using data from the Lithuanian Cancer Registry. Age-standardized incidence rates were calculated by sex, age, and histology. Trends were analyzed using the Joinpoint Regression Program to estimate the annual percent change. Results: A total of 3086 primary liver cancer cases were diagnosed, and 2923 patients died from liver cancer. The total number of liver cancer cases changed from 132 in 1998 to 239 in 2015. Liver cancer incidence rates changed during the study period from 5.02/100,000 in 1998 to 10.54/100,000 in 2015 in men and from 2.43/100,000 in 1998 to 6.25/100,000 in 2015 in women. Annual percentage changes (APCs) in the age-standardized rates over this period were 4.5% for incidence and 3.6% for mortality. Hepatocellular cancer incidence rates were stable from 1998 to 2005 (APC −5.9, p = 0.1) and later increased by 6.7% per year (p < 0.001). Intrahepatic ductal carcinoma incidence increased by 8.9% per year throughout the study period. The rise in incidence was observed in all age groups; however, in age groups < 50 and between 70 and 79 years, observed changes were not statistically significant. For mortality, the significant point of trend change was detected in 2001, where after stable mortality, rates started to increase by 2.4% per year. Conclusions: Primary liver cancer incidence and mortality increased in both sexes in Lithuania. The rise om incidence was observed in both sexes and main histology groups. The increasing incidence trend may be related to the prevalence of main risk factors (alcohol consumption, hepatitis B and C infections. and diabetes).

Download Full-text

Trends in prostate cancer incidence and mortality to monitor control policies in a northeastern Brazilian state

PLoS ONE ◽

10.1371/journal.pone.0249009 ◽

2021 ◽

Vol 16 (3) ◽

pp. e0249009

Author(s):

Carlos Anselmo Lima ◽

Brenda Evelin Barreto da Silva ◽

Evânia Curvelo Hora ◽

Marcela Sampaio Lima ◽

Erika de Abreu Costa Brito ◽

...

Keyword(s):

Prostate Cancer ◽

Screening Program ◽

Specific Antigen ◽

Mortality Rates ◽

Mortality Data ◽

Annual Percent Change ◽

Psa Screening ◽

Psa Testing ◽

Incidence And Mortality ◽

Over Time

Prostate cancer differently affects different regions of the world, displaying higher rates in more developed areas. After the implementation of prostate-specific antigen (PSA) testing, several studies described rising rates globally, but it is possible that indolent lesions are being detected given the lack of changes in mortality data. The Brazilian government recommends against PSA screening in the male population regardless of age, but the Urology Society issued a report recommending that screening should start at 50 years old for certain men and for those aged ≥75 years with a life expectancy exceeding 10 years. In this study, we examined the incidence and mortality rates of invasive prostate cancer over time in the Sergipe state of Brazil. The databases of the Aracaju Cancer Registry and Mortality Information System were used to calculate age-standardized rates for all prostate tumors (International Classification of Diseases 10th edition: C61 and D07.5) in the following age ranges: 20–44, 45–54, and ≥65 years. We identified 3595 cases of cancer, 30 glandular intraepithelial high-grade lesions, and 3269 deaths. Using the Joinpoint Regression Program, we found that the incidence of prostate cancer dramatically increased over time until the mid-2000s for all age groups, after which the rates declined. Prostate cancer mortality rates increased until 2005, followed by a non-significant annual percent change of 22.0 in 2001–2005 and a stable rate thereafter. We noticed that the increases and decreases of the incidence rates of prostate cancer were associated with the screening recommendations. Meanwhile, the increased mortality rates did not appear to be associated with decreased PSA testing; instead, they were linked to the effects of age and improvements in identification of the cause of death. Thus, we do not believe a PSA screening program would benefit the population of this study.

Download Full-text

The relationship between urologic cancer outcomes and national Human Development Index: trend from 2012 to 2018

10.21203/rs.2.14786/v1 ◽

2019 ◽

Author(s):

Nan Zhang ◽

Hua Mu ◽

Yan-rou Jiang ◽

Shi-geng Zhang

Keyword(s):

Prostate Cancer ◽

Cancer Incidence ◽

Survival Rates ◽

Substantial Reduction ◽

Mortality Rates ◽

Incidence Rates ◽

Cancer Outcomes ◽

Net Survival ◽

Incidence And Mortality ◽

Urologic Cancer

Abstract Objectives To describe the influence of the socioeconomic development on worldwide age-standardized incidence and mortality rates, as well as mortality-to-incidence ratio (MIR) and 5-year net survival of urologic cancer patients from 2012 to 2018. Methods The HDI values were obtained from the United Nations Development Programme, data on age-standardized incidence/mortality rates of prostate, bladder and kidney cancer were retrieved from the GLOBOCAN database, 5-year net survival was provided by the CONCORD-3 program. We then evaluated the association between incidence/MIR/survival and HDI, with a focus on geographic variability as well as temporal patterns during the last 6 years. Results Urologic cancer incidence rates were positively correlated with HDIs, and MIRs were negatively correlated with HDIs. Prostate cancer survival also correlated positively with HDIs, solidly confirming the interrelation among cancer indicators and socioeconomic factors. Most countries experienced incidence decline over the most recent 6 years, and a substantial reduction in MIR was observed. Survival rates of prostate cancer have simultaneously improved. Conclusion Development has a prominent influence on urologic cancer outcomes. HDI values are significantly correlated with cancer incidence, MIR and survival rates. HDI values have risen along with increased incidence and improved outcomes of urologic caner in recent years.

Download Full-text

Trends of colorectal cancer incidence and mortality rates from 2003 to 2014 in Italy

Tumori Journal ◽

10.1177/0300891619838336 ◽

2019 ◽

Vol 105 (5) ◽

pp. 417-426 ◽

Cited By ~ 2

Author(s):

Manuel Zorzi ◽

Luigino Dal Maso ◽

Silvia Francisci ◽

Carlotta Buzzoni ◽

Massimo Rugge ◽

...

Keyword(s):

Colorectal Cancer ◽

Age Groups ◽

Geographic Area ◽

Cancer Registries ◽

Mortality Rates ◽

Incidence Rates ◽

Annual Percent Change ◽

Screening Programs ◽

Italian Regions ◽

Incidence And Mortality

Objective: To evaluate the trends of colorectal cancer (CRC) incidence and mortality rates from 2003 to 2014 in Italy by age groups and regions. Methods: We used the data of 48 cancer registries from 17 Italian regions to estimate standardized incidence and mortality rates overall and by sex, age groups (<50, 50–69, 70+ years), and geographic area (northwest, northeast, center, south, and islands). Time trends were expressed as annual percent change in rates (APC) with 95% confidence intervals (95% CI). Results: Incidence rates decreased from 104.3 (2003) to 89.9 × 100,000 (2014) in men and from 64.3 to 58.4 × 100,000 in women. Among men, incidence decreased during 2007–2010 (APC −4.0, 95% CI −6.0 to −1.9) and 2010–2014 (APC −0.7, 95% CI −1.4 to 0.0), while in women it linearly decreased during the whole period (APC −1.1, 95% CI −1.4 to −0.8). Mortality rates showed a linear reduction both in men (APC −0.7, 95% CI −1.0 to −0.3) and women (APC −0.9, 95% CI −1.2 to −0.6) and decreased respectively from 41.1 to 39.2 × 100,000 and from 24.6 to 23.1 × 100,000. In the 50- to 69-year-old range (screening target age), incidence showed a prescreening increase, followed by a peak after screening started, and a decline thereafter. Incidence and mortality rates significantly decreased in all areas but in the south and islands, where incidence increased and mortality remained stable. Conclusions: A renewed commitment by all regional health systems to invest in primary (i.e., lifestyle) and secondary (i.e., screening programs) prevention is of utmost importance.

Download Full-text